<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02418390</url>
  </required_header>
  <id_info>
    <org_study_id>H-1404-050-571</org_study_id>
    <nct_id>NCT02418390</nct_id>
  </id_info>
  <brief_title>The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma</brief_title>
  <official_title>The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the efficacy and safety of prophylactic central lymph
      node dissection in papillary thyroid carcinoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to investigate the efficacy and safety of prophylactic central lymph
      node dissection in papillary thyroid carcinoma. Primary outcome is the structural recurrence
      rate. Secondary outcomes are operative time, postoperative complications, and quality of
      life.

      The enrolled patients were randomly assigned to control group and intervention group (1:1
      allocation).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of thyroid cancer</measure>
    <time_frame>Participants will be followed from the operation to 7 year (maximum)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>operation time</measure>
    <time_frame>up to 6 hours after operation</time_frame>
    <description>operation time will be measured by attending nurse</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications including hypoparathyroidism and recurrent nerve palsy</measure>
    <time_frame>6 months postoperatively</time_frame>
    <description>At outpatient clinic (6months posteoperatively), video laryngoscopic exam and serum parathyroid hormone with serum calcium will be measured. Type and number of complications will be recoreded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>9 months postoperatively</time_frame>
    <description>Quality of life will be measured by using SF-36 questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">5750</enrollment>
  <condition>Thyroid Cancer, Papillary</condition>
  <arm_group>
    <arm_group_label>No prophylactic central dissection</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients underwent total thyroidectomy for papillary thyroid carcinoma, without prophylactic central lymph node dissection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prophylactic central dissection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients underwent total thyroidectomy for papillary thyroid carcinoma, with prophylactic central lymph node dissection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>prophylactic central lymph node dissection</intervention_name>
    <description>dissection of level VI compartment by AAHNS (American association of head and neck surgeons) classification</description>
    <arm_group_label>Prophylactic central dissection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  no clinical and radiological evidence of lymph node metastasis

          -  no evidence of hyperparathyroidism

        Exclusion Criteria:

          -  pregnant women

          -  uncontrolled diabetes, hypertension, or chronic renal failure

          -  aspirin or anticoagulant medication within 7 days

          -  other clinical trial participation within 30 days

          -  radiation exposure to the head and neck

          -  previous operation to the neck

          -  advanced thyroid cancer including adjacent organ invasion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyu Eun Lee, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyungju Kwon, MD, MS</last_name>
    <phone>+82-2-2072-2096</phone>
    <email>lovekkung@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyu Eun Lee, Ph.D</last_name>
      <email>kyu.eun.lee.md@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Kyu Eun Lee, MD, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <results_reference>
    <citation>Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT, Kloos RT, Mazzaferri EL Sr, Peduzzi PN, Roman SA, Sippel RS, Sosa JA, Stack BC Jr, Steward DL, Tufano RP, Tuttle RM, Udelsman R; American Thyroid Association Surgical Affairs Committee. American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid. 2012 Mar;22(3):237-44. doi: 10.1089/thy.2011.0317. Epub 2012 Feb 7.</citation>
    <PMID>22313454</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2015</study_first_submitted>
  <study_first_submitted_qc>April 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2015</study_first_posted>
  <last_update_submitted>October 23, 2016</last_update_submitted>
  <last_update_submitted_qc>October 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Kyu Eun Lee</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

